Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Velcade in Relapsed or Refractory Follicular B-cell Lymphoma
2005-000734-21Phase 2Completed
- Sponsor
- Lymphoma Study Association
- Start
- Feb 2006
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bortezomib in follicular lymphoma (FL), sponsored by Lymphoma Study Association. Primary endpoint: Primary disease response rate. Started Feb 2006; status: completed.
02
Drugs
bortezomib
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on 2005-000734-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000734-21.